These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23477549)

  • 1. Point-of-care routine rapid screening: the future of cancer diagnosis?
    Bossmann SH; Troyer DL
    Expert Rev Mol Diagn; 2013 Mar; 13(2):107-9. PubMed ID: 23477549
    [No Abstract]   [Full Text] [Related]  

  • 2. Systems medicine: a real approach for future personalized oncology?
    Roukos DH
    Pharmacogenomics; 2010 Mar; 11(3):283-7. PubMed ID: 20235782
    [No Abstract]   [Full Text] [Related]  

  • 3. Personalized cancer medicine.
    Marmé D; Hallek M
    Onkologie; 2012; 35 Suppl 1():2. PubMed ID: 22286580
    [No Abstract]   [Full Text] [Related]  

  • 4. Biomarkers and oncology: the path forward to a learning health system.
    Yu PP; Hoffman MA; Hayes DF
    Arch Pathol Lab Med; 2015 Apr; 139(4):451-6. PubMed ID: 25152310
    [No Abstract]   [Full Text] [Related]  

  • 5. Translational medicine promising personalized therapy in oncology.
    Zeng YX; Zhang XS; Liu Q
    Front Med China; 2010 Dec; 4(4):351-5. PubMed ID: 21107749
    [No Abstract]   [Full Text] [Related]  

  • 6. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["Hidden hierarchical thinking is not up to date anymore": an interview with Johannes Bruns by Stephanie Hügler].
    Bruns J
    Dtsch Med Wochenschr; 2011 Apr; 136 Suppl 1():S20-2. PubMed ID: 21452102
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical research and human and social sciences at Institut National du Cancer (INCa)].
    Amsellem N
    Med Sci (Paris); 2012 Mar; 28 Spec No 1():6. PubMed ID: 22494649
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Petrelli NJ; Winer EP; Brahmer J; Dubey S; Smith S; Thomas C; Vahdat LT; Obel J; Vogelzang N; Markman M; Sweetenham JW; Pfister D; Kris MG; Schuchter LM; Sawaya R; Raghavan D; Ganz PA; Kramer B
    J Clin Oncol; 2009 Dec; 27(35):6052-69. PubMed ID: 19901123
    [No Abstract]   [Full Text] [Related]  

  • 10. The cancer genome and diagnostic blood tests.
    Lance P
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2017-8. PubMed ID: 17119024
    [No Abstract]   [Full Text] [Related]  

  • 11. It is fascinating to see how nowadays more and more knowledge of the molecular biological characteristics of the tumour lead to individualisation with surgery, radiotherapy and systemic treatment for patients with a malignancy. Introduction.
    Bartelink H
    Eur J Cancer; 2011 Sep; 47 Suppl 3():xxxv. PubMed ID: 21944037
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of molecular diagnostics in cancer diagnosis and treatment.
    Ozretić L; Heukamp LC; Odenthal M; Buettner R
    Onkologie; 2012; 35 Suppl 1():8-12. PubMed ID: 22286582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction for: frontiers of personalized cancer medicine.
    Kucherlapati R
    Cancer J; 2011; 17(6):403-4. PubMed ID: 22157283
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer research--from bench to bedside.
    Izraeli S; Witz I; Micksche M
    Isr Med Assoc J; 2002 Sep; 4(9):746-8. PubMed ID: 12440253
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent developments and future perspectives of personalized oncology.
    Grüllich C; von Kalle C
    Onkologie; 2012; 35 Suppl 1():4-7. PubMed ID: 22286581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological network modelling and precision medicine in oncology].
    Calzone L; Kuperstein I; Cohen D; Grieco L; Bonnet E; Servant N; Hupé P; Zinovyev A; Barillot E
    Bull Cancer; 2014 Jun; 101 Suppl 1():S18-21. PubMed ID: 24966078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perspectives on psycho-oncology and tumor-related fatigue].
    Heussner P
    Wien Med Wochenschr; 2005 Dec; 155(23-24):544-8. PubMed ID: 16425009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal cancer care across the spectrum of life and disease.
    Lyman GH; Hauser RS
    Am J Manag Care; 2008 May; 14(5):262-4. PubMed ID: 18471030
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolomics in paediatric oncology: a potential still to be exploited.
    Spiga L; Atzori L; Noto A; Moretti C; Mussap M; Masile A; Lussu M; Fanos V
    J Matern Fetal Neonatal Med; 2013 Oct; 26 Suppl 2():20-3. PubMed ID: 24059547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.